Financials

  • Market Capitalization 402.54 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-2.14
Índice preço/fluxo de caixa
26.03

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
3054
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
14.82 USD-8.35%+11.26%+157.74%-12.98%421.23 M USD
3056
GALT
Galectin Therapeutics Inc. - Common Stock
4.07 USD-1.69%+9.41%+18.66%-3.10%410.46 M USD
3063
FENC
Fennec Pharmaceuticals Inc. - Common Stock
12.37 USD+5.10%+8.03%+22.96%+38.06%433.78 M USD
3071
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.80 USD-3.81%-2.24%+9.34%-0.21%393.82 M USD

Notícias